If you have been reading about Dihexa and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-07-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic angiotensin IV analog | Peptidomimetic |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in DMSO; limited in water | Typical for small peptides |
| Storage | -20 °C, desiccated | Protect from light and moisture |
| Analytical method | HPLC with UV detection | Purity and identity checks |
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
== Structure prediction == Some bioinformatics methods have been developed for predicting the quaternary structural attributes of proteins based on their sequence information by using various modes of pseudo amino acid composition. Protein folding prediction programs used to predict protein tertiary structure have also been expanding to better predict protein quaternary structure. One such development is AlphaFold-Multimer built upon the AlphaFold model for predicting protein tertiary structure.
==== Calorimetry errors ==== The calculation of excess heat in electrochemical cells involves certain assumptions. Errors in these assumptions have been offered as non-nuclear explanations for excess heat. One assumption made by Fleischmann and Pons is that the efficiency of electrolysis is nearly 100%, meaning nearly all the electricity applied to the cell resulted in electrolysis of water, with negligible resistive heating and substantially all the electrolysis product leaving the cell unchanged. This assumption gives the amount of energy expended converting liquid D2O into gaseous D2 and O2. The efficiency of electrolysis is less than one if hydrogen and oxygen recombine to a significant extent within the calorimeter. Several researchers have described potential mechanisms by which this process could occur and thereby account for excess heat in electrolysis experiments. Another assumption is that heat loss from the calorimeter maintains the same relationship with measured temperature as found when calibrating the calorimeter. This assumption ceases to be accurate if the temperature distribution within the cell becomes significantly altered from the condition under which calibration measurements were made. This can happen, for example, if fluid circulation within the cell becomes significantly altered. Recombination of hydrogen and oxygen within the calorimeter would also alter the heat distribution and invalidate the calibration.
Anirudh Ravichander composed Darbar's soundtrack and score, marking his second collaboration with Rajinikanth after Petta (2019) and also with director A. R. Murugadoss after Kaththi (2014). "Thalaivar Theme", an instrumental theme for the film, was released on 7 November 2019 to accompany the motion poster. The film's first single "Chumma Kizhi", whose lyrics were written by Vivek and sung by S. P. Balasubrahmanyam, was released on 27 November 2019. The film's album was launched on 7 December 2019 at Jawaharlal Nehru Indoor Stadium, Chennai, in the presence of the film's cast and crew; it was made available to stream through the online streaming platform Gaana on the same day. The film's soundtrack has an unreleased hidden song titled "Kannula Thimiru", which was recorded by trans-woman singers Chandramukhi, Rachana and Priya Murthi, and was performed live at the film's audio launch. For the song, Anirudh engaged veteran composer Deva to conduct the song's brass section; a making-of video of the song was released in mid January 2020 and went viral on the internet. Sify stated "the soundtrack album is quite disappointing as compared to Rajinikanth's earlier film Petta, due to the unimpressive lyrics but it touches the listener's soul and enables them to sing along".
Sources: en.wikipedia.org
2GO and its subsidiaries (collectively referred to as the Group) provide shipping, logistics, and distribution services to small and medium enterprises, large corporations, and government agencies throughout the Philippines. The Group operates under its flagship brand, 2GO. The Group's shipping operations manage inter-island roll-on/roll-off (RoRo) freight and passenger vessels. Its logistics arm offers transportation, warehousing, and distribution services, including cold chain solutions, domestic and international ocean and air forwarding, customs brokerage, project logistics, and express and last-mile package and e-commerce delivery. The distribution segment complements these operations by leveraging 2GO's shipping and logistics capabilities to provide value-added distribution services to principals and customers.
== Additional sources == Birkhead T, Wimpenny J; Montgomerie B (2014). Ten Thousand Birds: Ornithology since Darwin. Princeton University Press. ISBN 978-0-691-15197-7. Chansigaud, Valerie (2009). History of Ornithology. London: New Holland Publishers. ISBN 978-1-84773-433-4. Gurney, John Henry (1921). "Early annals of ornithology". Nature. 108 (2713): 268. Bibcode:1921Natur.108..268.. doi:10.1038/108268a0. hdl:2027/coo.31924090299532. S2CID 4033666. Retrieved 19 November 2010. Newton, Alfred (1884). Ornithology. [S.l. : s.n.(Reprinted from the 1884 Encyclopædia Britannica) Podulka, Sandy; Eckhardt, Marie; Otis, Daniel (2001). "Birds and Humans: A Historical Perspective". In Podulka, Sandy; Rohrbaugh, Ronald W.; Bonney, Rick (eds.). Handbook of Bird Biology (2nd ed.). Ithaca, NY: Cornell Lab of Ornithology. pp. H1–H42. ISBN 978-0-938027-62-1. Walters, Michael (2005). A Concise History of Ornithology. New Haven, CT: Yale University Press. ISBN 978-1-84773-433-4.
=== Etymology === The word diabetes ( or ) comes from Latin diabētēs, which in turn comes from Ancient Greek διαβήτης (diabētēs), which literally means "a passer through; a siphon". Ancient Greek physician Aretaeus of Cappadocia (fl. 2nd century CE) used that word, with the intended meaning "excessive discharge of urine", as the name for the disease. Ultimately, the word comes from Greek διαβαίνειν (diabainein), meaning "to pass through", which is composed of δια- (dia-), meaning "through" and βαίνειν (bainein), meaning "to go". The word "diabetes" is first recorded in English, in the form diabete, in a medical text written around 1425. The word mellitus ( or ) comes from the classical Latin word mellītus, meaning "mellite" (i.e. sweetened with honey; honey-sweet). The Latin word comes from mell-, which comes from mel, meaning "honey"; sweetness; pleasant thing, and the suffix -ītus, whose meaning is the same as that of the English suffix "-ite". It was Thomas Willis who in 1675 added "mellitus" to the word "diabetes" as a designation for the disease, when he noticed the urine of a person with diabetes had a sweet taste (glycosuria). This sweet taste had been noticed in urine by the ancient Greeks, Chinese, Egyptians, and Indians.
=== Adam Goodes–Eddie McGuire racism controversy === Late in the final quarter of the round 9 match between Collingwood and Sydney, Adam Goodes became the target of racial abuse in which a 13-year-old Collingwood supporter called him an "ape". Goodes pointed the supporter out to security following the incident, who subsequently evicted her from the ground; after the match, Collingwood president Eddie McGuire visited the Swans' rooms to apologise "on behalf of football", and stamped out that racism would not be tolerated by the Collingwood Football Club. Five days later, McGuire was involved in another controversy involving Goodes on his Triple M Melbourne breakfast show, when he joked that Goodes could be used to promote the King Kong musical that was to be held in Melbourne, quickly apologising on air after making the reference. McGuire initially defended his comments by saying that the remark was simply "a slip of the tongue", but admitted to vilifying Goodes in an interview later in the day, albeit unintentionally.
Sources: en.wikipedia.org
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.
No major drug regulatory agency has approved dihexa for human use. Published human clinical trials are absent, so its safety and efficacy are not established. It is commonly sold for laboratory research only.
It was developed from research on angiotensin IV analogs and peptide stability. The goal was to find compounds with better brain penetration and metabolic resistance. Early studies used rodent models rather than human participants.
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.